Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Münger K[au]:

Human papillomavirus molecular biology. Harden ME et al. Mutat Res Rev Mutat Res. (2017)

Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update. Ascherio A et al. Semin Neurol. (2016)

EBV and Autoimmunity. Ascherio A et al. Curr Top Microbiol Immunol. (2015)

Search results

Items: 1 to 50 of 310

1.

Reply to letter to the editor.

de Jong HJI, Tremlett H, Zhu F, Ascherio A, Munger KL.

Mult Scler Relat Disord. 2019 Sep;34:165. doi: 10.1016/j.msard.2019.06.025. Epub 2019 Jun 20. No abstract available.

PMID:
31543260
2.

Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis.

Bjornevik K, Munger KL, Cortese M, Barro C, Healy BC, Niebuhr DW, Scher AI, Kuhle J, Ascherio A.

JAMA Neurol. 2019 Sep 13. doi: 10.1001/jamaneurol.2019.3238. [Epub ahead of print]

PMID:
31515562
3.

University of South Dakota Sanford School of Medicine Community Project Abstracts.

Cooper R, Eggers A, Ervin Person M, Haines A, Munger K, Weber G.

S D Med. 2019 Jul;72(7):314-321. No abstract available.

PMID:
31461587
4.

Rotating night shift work and risk of multiple sclerosis in the Nurses' Health Studies.

Papantoniou K, Massa J, Devore E, Munger KL, Chitnis T, Ascherio A, Schernhammer ES.

Occup Environ Med. 2019 Oct;76(10):733-738. doi: 10.1136/oemed-2019-106016. Epub 2019 Aug 12.

PMID:
31405910
5.

Measuring and Explaining Political Sophistication through Textual Complexity.

Benoit K, Munger K, Spirling A.

Am J Pol Sci. 2019 Apr;63(2):491-508. doi: 10.1111/ajps.12423. Epub 2019 Mar 18.

6.

Epstein-barr virus and multiple sclerosis risk in the finnish maternity cohort.

Munger KL, Hongell K, Cortese M, Åivo J, Soilu-Hänninen M, Surcel HM, Ascherio A.

Ann Neurol. 2019 Sep;86(3):436-442. doi: 10.1002/ana.25532. Epub 2019 Jul 3.

PMID:
31226219
7.

Total intake of different minerals and the risk of multiple sclerosis.

Cortese M, Chitnis T, Ascherio A, Munger KL.

Neurology. 2019 Apr 30;92(18):e2127-e2135. doi: 10.1212/WNL.0000000000006800. Epub 2019 Apr 3.

PMID:
30944237
8.

PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis.

Hatterschide J, Bohidar AE, Grace M, Nulton TJ, Kim HW, Windle B, Morgan IM, Munger K, White EA.

Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7033-7042. doi: 10.1073/pnas.1819534116. Epub 2019 Mar 20.

9.

Animal exposure over the life-course and risk of multiple sclerosis: A case-control study within two cohorts of US women.

de Jong HJI, Tremlett H, Zhu F, Ascherio A, Munger KL.

Mult Scler Relat Disord. 2019 Jan;27:327-332. doi: 10.1016/j.msard.2018.11.015. Epub 2018 Nov 15.

PMID:
30471586
10.

Diet quality and risk of multiple sclerosis in two cohorts of US women.

Rotstein DL, Cortese M, Fung TT, Chitnis T, Ascherio A, Munger KL.

Mult Scler. 2018 Oct 23:1352458518807061. doi: 10.1177/1352458518807061. [Epub ahead of print]

PMID:
30351179
11.

More than just oncogenes: mechanisms of tumorigenesis by human viruses.

Gaglia MM, Munger K.

Curr Opin Virol. 2018 Oct;32:48-59. doi: 10.1016/j.coviro.2018.09.003. Epub 2018 Sep 27. Review.

12.

Exercise prevents HFD- and OVX-induced type 2 diabetes risk factors by decreasing fat storage and improving fuel utilization.

Gorres-Martens BK, Field TJ, Schmidt ER, Munger KA.

Physiol Rep. 2018 Jul;6(13):e13783. doi: 10.14814/phy2.13783.

13.

Author response: 25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort.

Munger KL, Ascherio A, Soilu-Hänninen M, Surcel HM, Åivo J.

Neurology. 2018 Apr 3;90(14):668-669. doi: 10.1212/WNL.0000000000005245. No abstract available.

PMID:
29610235
14.

Inhibition of TGF-β and NOTCH Signaling by Cutaneous Papillomaviruses.

Meyers JM, Grace M, Uberoi A, Lambert PF, Munger K.

Front Microbiol. 2018 Mar 8;9:389. doi: 10.3389/fmicb.2018.00389. eCollection 2018. Review.

15.

Mapping metabolic changes by noninvasive, multiparametric, high-resolution imaging using endogenous contrast.

Liu Z, Pouli D, Alonzo CA, Varone A, Karaliota S, Quinn KP, Münger K, Karalis KP, Georgakoudi I.

Sci Adv. 2018 Mar 7;4(3):eaap9302. doi: 10.1126/sciadv.aap9302. eCollection 2018 Mar.

16.

Sun exposure over the life course and associations with multiple sclerosis.

Tremlett H, Zhu F, Ascherio A, Munger KL.

Neurology. 2018 Apr 3;90(14):e1191-e1199. doi: 10.1212/WNL.0000000000005257. Epub 2018 Mar 7.

17.

Expert Views on HPV Infection.

McBride AA, Münger K.

Viruses. 2018 Feb 24;10(2). pii: E94. doi: 10.3390/v10020094. No abstract available.

19.

The curious case of APOBEC3 activation by cancer-associated human papillomaviruses.

Wallace NA, Münger K.

PLoS Pathog. 2018 Jan 11;14(1):e1006717. doi: 10.1371/journal.ppat.1006717. eCollection 2018 Jan. No abstract available.

20.

The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.

Chiang C, Pauli EK, Biryukov J, Feister KF, Meng M, White EA, Münger K, Howley PM, Meyers C, Gack MU.

J Virol. 2018 Feb 26;92(6). pii: e01737-17. doi: 10.1128/JVI.01737-17. Print 2018 Mar 15.

21.

KDM6A addiction of cervical carcinoma cell lines is triggered by E7 and mediated by p21CIP1 suppression of replication stress.

Soto DR, Barton C, Munger K, McLaughlin-Drubin ME.

PLoS Pathog. 2017 Oct 2;13(10):e1006661. doi: 10.1371/journal.ppat.1006661. eCollection 2017 Oct.

22.

Reply to "Stratified analyses are necessary to verify the influence of salt intake in multiple sclerosis".

Fitzgerald KC, Munger KL, Ascherio A.

Ann Neurol. 2017 Oct;82(4):649. doi: 10.1002/ana.25055. Epub 2017 Oct 10. No abstract available.

PMID:
28961335
23.

Exposure to particulate matter air pollution and risk of multiple sclerosis in two large cohorts of US nurses.

Palacios N, Munger KL, Fitzgerald KC, Hart JE, Chitnis T, Ascherio A, Laden F.

Environ Int. 2017 Dec;109:64-72. doi: 10.1016/j.envint.2017.07.013. Epub 2017 Sep 20.

PMID:
28938101
24.

25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort.

Munger KL, Hongell K, Åivo J, Soilu-Hänninen M, Surcel HM, Ascherio A.

Neurology. 2017 Oct 10;89(15):1578-1583. doi: 10.1212/WNL.0000000000004489. Epub 2017 Sep 13.

25.

Crowd Control: E7 Conservation Is the Key to Cancer.

White EA, Munger K.

Cell. 2017 Sep 7;170(6):1057-1059. doi: 10.1016/j.cell.2017.08.033.

26.

No association between dietary sodium intake and the risk of multiple sclerosis.

Cortese M, Yuan C, Chitnis T, Ascherio A, Munger KL.

Neurology. 2017 Sep 26;89(13):1322-1329. doi: 10.1212/WNL.0000000000004417. Epub 2017 Aug 25.

27.

Expanding the Mental Health Workforce in China: Narrowing the Mental Health Service Gap.

Hu X, Rohrbaugh R, Deng Q, He Q, Munger KF, Liu Z.

Psychiatr Serv. 2017 Oct 1;68(10):987-989. doi: 10.1176/appi.ps.201700002. Epub 2017 Aug 15. Review.

PMID:
28806895
28.

Author response: Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.

Nielsen NM, Munger KL, Stenager E, Ascherio A.

Neurology. 2017 Jul 25;89(4):411. doi: 10.1212/WNL.0000000000004140. No abstract available.

PMID:
28739666
29.

A Mathematical Model of Cell Cycle Dysregulation Due to Human Papillomavirus Infection.

Miller AK, Munger K, Adler FR.

Bull Math Biol. 2017 Jul;79(7):1564-1585. doi: 10.1007/s11538-017-0299-9. Epub 2017 Jun 12.

30.

Sodium intake and multiple sclerosis activity and progression in BENEFIT.

Fitzgerald KC, Munger KL, Hartung HP, Freedman MS, Montalbán X, Edan G, Wicklein EM, Radue EW, Kappos L, Pohl C, Ascherio A; BENEFIT Study Group.

Ann Neurol. 2017 Jul;82(1):20-29. doi: 10.1002/ana.24965.

31.

Human papillomavirus molecular biology.

Harden ME, Munger K.

Mutat Res Rev Mutat Res. 2017 Apr - Jun;772:3-12. doi: 10.1016/j.mrrev.2016.07.002. Epub 2016 Jul 5. Review.

32.

Human papillomavirus 16 E6 and E7 oncoprotein expression alters microRNA expression in extracellular vesicles.

Harden ME, Munger K.

Virology. 2017 Aug;508:63-69. doi: 10.1016/j.virol.2017.05.005. Epub 2017 May 10.

33.

Perturbation of DROSHA and DICER expression by human papillomavirus 16 oncoproteins.

Harden ME, Munger K.

Virology. 2017 Jul;507:192-198. doi: 10.1016/j.virol.2017.04.022. Epub 2017 Apr 24.

34.

Polyunsaturated fatty acids and the risk of multiple sclerosis.

Bjørnevik K, Chitnis T, Ascherio A, Munger KL.

Mult Scler. 2017 Dec;23(14):1830-1838. doi: 10.1177/1352458517691150. Epub 2017 Feb 3.

35.

Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation.

Meyers JM, Uberoi A, Grace M, Lambert PF, Munger K.

PLoS Pathog. 2017 Jan 20;13(1):e1006171. doi: 10.1371/journal.ppat.1006171. eCollection 2017 Jan.

36.

Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.

Harden ME, Prasad N, Griffiths A, Munger K.

MBio. 2017 Jan 3;8(1). pii: e02170-16. doi: 10.1128/mBio.02170-16.

37.

Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.

Nielsen NM, Munger KL, Koch-Henriksen N, Hougaard DM, Magyari M, Jørgensen KT, Lundqvist M, Simonsen J, Jess T, Cohen A, Stenager E, Ascherio A.

Neurology. 2017 Jan 3;88(1):44-51. doi: 10.1212/WNL.0000000000003454. Epub 2016 Nov 30.

38.

Physical activity and the incidence of multiple sclerosis.

Dorans KS, Massa J, Chitnis T, Ascherio A, Munger KL.

Neurology. 2016 Oct 25;87(17):1770-1776. Epub 2016 Sep 28.

39.

Proteomic analysis of the gamma human papillomavirus type 197 E6 and E7 associated cellular proteins.

Grace M, Munger K.

Virology. 2017 Jan;500:71-81. doi: 10.1016/j.virol.2016.10.010. Epub 2016 Oct 20.

40.

High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation.

White EA, Münger K, Howley PM.

MBio. 2016 Sep 20;7(5). pii: e01530-16. doi: 10.1128/mBio.01530-16.

41.

People with MS should consume a low-salt diet - NO.

Ascherio A, Munger KL.

Mult Scler. 2016 Dec;22(14):1779-1781. Epub 2016 Sep 8. No abstract available.

PMID:
27609133
42.

Viruses and Cancer: An Accidental Journey.

Munger K.

PLoS Pathog. 2016 Sep 8;12(9):e1005573. doi: 10.1371/journal.ppat.1005573. eCollection 2016 Sep. No abstract available.

43.

Hormone therapy use and physical quality of life in postmenopausal women with multiple sclerosis.

Bove R, White CC, Fitzgerald KC, Chitnis T, Chibnik L, Ascherio A, Munger KL.

Neurology. 2016 Oct 4;87(14):1457-1463. Epub 2016 Sep 7.

44.

Epidemiology of Major Neurodegenerative Diseases in Women: Contribution of the Nurses' Health Study.

Hagan KA, Munger KL, Ascherio A, Grodstein F.

Am J Public Health. 2016 Sep;106(9):1650-5. doi: 10.2105/AJPH.2016.303324. Epub 2016 Jul 26. Review.

45.

Weighing Evidence from Mendelian Randomization-Early-Life Obesity as a Causal Factor in Multiple Sclerosis?

Ascherio A, Munger KL.

PLoS Med. 2016 Jun 28;13(6):e1002054. doi: 10.1371/journal.pmed.1002054. eCollection 2016 Jun.

46.

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

Sena A, Capela C, Ferret-Sena V, Munger KL, Ascherio A, Suarez G.

Neurology. 2016 May 24;86(21):2026. doi: 10.1212/01.wnl.0000484266.87397.05. No abstract available.

PMID:
27217468
47.

Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update.

Ascherio A, Munger KL.

Semin Neurol. 2016 Apr;36(2):103-14. doi: 10.1055/s-0036-1579693. Epub 2016 Apr 26. Review.

PMID:
27116717
48.

Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort.

Munger KL, Åivo J, Hongell K, Soilu-Hänninen M, Surcel HM, Ascherio A.

JAMA Neurol. 2016 May 1;73(5):515-9. doi: 10.1001/jamaneurol.2015.4800.

49.

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.

Fitzgerald KC, Munger KL, Köchert K, Arnason BG, Comi G, Cook S, Goodin DS, Filippi M, Hartung HP, Jeffery DR, O'Connor P, Suarez G, Sandbrink R, Kappos L, Pohl C, Ascherio A.

JAMA Neurol. 2015 Dec;72(12):1458-65. doi: 10.1001/jamaneurol.2015.2742.

PMID:
26458124
50.

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

Munger KL, Fitzgerald KC, Freedman MS, Hartung HP, Miller DH, Montalbán X, Edan G, Barkhof F, Suarez G, Radue EW, Sandbrink R, Kappos L, Pohl C, Ascherio A.

Neurology. 2015 Nov 10;85(19):1694-701. doi: 10.1212/WNL.0000000000002099. Epub 2015 Oct 9.

Supplemental Content

Loading ...
Support Center